Feature

Psychiatric subspecialty is changing its name


 

Constantine G. Lyketsos, MD, remembers when the Academy of Psychosomatic Medicine held annual meetings that attracted 200. Now, the subspecialty organization’s meeting attracts about 1,000 people, and is getting a new name to reflect that growth.

“The field has grown substantially, and I think it will grow further with this name change,” said Dr. Lyketsos, who along with James L. Levenson, MD, spearheaded the effort to have the subspecialty recognized almost 20 years ago. “The field is the same. [But the] name change is going to change the way we are perceived by our primary customers – the patients. It will probably be a positive development for our trainees.”


The organization will be rebranded as the Academy of Consultation-Liaison Psychiatry. The name change, aimed in part at shedding the ambiguity around the word “psychosomatic” and better capturing the mission of consultation-liaison psychiatry, will be reflected across the group’s platforms. The tagline on the group’s journal, Psychosomatics, will become “The Journal of Consultation-Liaison Psychiatry,” and the theme of the group’s November 2018 annual meeting in Orlando will focus on the rebranding. The academy also has changed its web address to clpsychiatry.org.

“I’m a consultation-liaison psychiatrist, and I think that clears the air from the very beginning,” said Dr. Lyketsos, professor and chair of psychiatry at Johns Hopkins Bayview in Baltimore.

Pages

Recommended Reading

Exenatide improved motor function in Parkinson’s patients with off-medication symptoms
MDedge Family Medicine
Poor smell predicts 6-year risk of Parkinson’s
MDedge Family Medicine
Slow-wave sleep linked to Parkinson’s disease cognition
MDedge Family Medicine
Driving ability of Parkinson’s patients can decline quickly
MDedge Family Medicine
High-intensity treadmill workouts preserved motor function in early-stage Parkinson’s
MDedge Family Medicine
Gene silencer reduces mutant huntingtin protein in early-stage Huntington’s patients
MDedge Family Medicine
FDA cites manufacturer of autologous stem cells for regulatory, manufacturing missteps
MDedge Family Medicine
Mutations on LRRK2 gene modify risks for both Crohn’s and Parkinson’s
MDedge Family Medicine
Distinguish neurogenic from nonneurogenic orthostatic hypotension
MDedge Family Medicine
MDedge Daily News: Could gut bacteria trigger lupus?
MDedge Family Medicine